Autoimmune Skin Disorders: Current Research

Autoimmune diseases of the skin occur when the immune system attacks normal skin. The immune system can be broadly divided into an effector arm responsible for fighting infections and cancer and a regulatory arm that reduces autoreactivity and maintains immune homeostasis. Cutaneous autoimmunity develops when the equilibrium between the effector arm and regulatory arm of the immune system is disrupted. Recent insights into the inflammatory pathways that are overactive in some cutaneous autoimmune diseases have led to therapies targeting the effector arm of the immune system with greater treatment efficacy than previously used broad immunosuppressants. The current paradigm of inhibiting excessive immune activation for treating cutaneous autoimmunity will be discussed including cytokine blockade, cellular depletion, intracellular signaling blockade and costimulatory blockade. 

    Related Conference of Autoimmune Skin Disorders: Current Research

    April 10-11, 2025

    27th World Dermatology and Aesthetic Congress

    Dubai, UAE
    May 20-21, 2025

    30th International Conference on Dermatology & Skin Care

    Zurich, Switzerland
    June 12-13, 2025

    8th World Cosmetic and Dermatology Congress

    London, UK
    July 28-29, 2025

    25th European Dermatology Congress

    Paris, France
    August 20-21, 2025

    26th World Dermatology Congress

    Paris, France
    August 21-22, 2025

    8th International Dermatology and Cosmetology Congress

    Dublin, Ireland
    September 15-16, 2025

    24th International Conference on Dermatology and Skin Care Sciences

    Aix-en-Provence, France

    Autoimmune Skin Disorders: Current Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in